Literature DB >> 19445963

Distinguishing childhood absence epilepsy patients from controls by the analysis of their background brain electrical activity (II): a combinatorial optimization approach for electrode selection.

Osvaldo A Rosso1, Alexandre Mendes, Regina Berretta, John A Rostas, Mick Hunter, Pablo Moscato.   

Abstract

In this sequel to our previous work [Rosso OA, Mendes A, Rostas JA, Hunter M, Moscato P. Distinguishing childhood absence epilepsy patients from controls by the analysis of their background brain electrical activity. J. Neurosci. Methods 2009;177:461-68], we extend the analysis of background electroencephalography (EEG), recorded with scalp electrodes in a clinical setting, in children with childhood absence epilepsy (CAE) and control individuals. The same set of individuals was considered-five CAE patients, all right-handed females and aged 6-8 years. The EEG was obtained using bipolar connections from a standard 10-20 electrode placement. The functional activity between electrodes was evaluated using a wavelet decomposition in conjunction with the Wootters distance. In the previous study, a Kruskal-Wallis statistical test was used to select the pairs of electrodes with differentiated behavior between CAE and control samples (classes). In this contribution, we present the results for a combinatorial optimization approach to select the pairs of electrodes. The new method produces a better separation between the classes, and at the same time uses a smaller number of features (pairs of electrodes). It managed to almost halve the number of features and also improves the separation between the CAE and control samples. The new results strengthen the hypothesis that mostly fronto-central electrodes carry useful information and patterns that can help to discriminate CAE cases from controls. Finally, we provide a comprehensive set of tests and in-depth explanation of the method and results.

Entities:  

Mesh:

Year:  2009        PMID: 19445963     DOI: 10.1016/j.jneumeth.2009.04.028

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  6 in total

1.  Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease.

Authors:  Mateus Rocha de Paula; Martín Gómez Ravetti; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

2.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

3.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

4.  Balancing Clinical and Pathologic Relevence in the Machine Learning Diagnosis of Epilepsy.

Authors:  Wesley T Kerr; Andrew Y Cho; Ariana Anderson; Pamela K Douglas; Edward P Lau; Eric S Hwang; Kaavya R Raman; Aaron Trefler; Mark S Cohen; Stefan T Nguyen; Navya M Reddy; Daniel H Silverman
Journal:  Int Workshop Pattern Recognit Neuroimaging       Date:  2013-06

5.  Adaptive neuro-fuzzy inference system for classification of background EEG signals from ESES patients and controls.

Authors:  Zhixian Yang; Yinghua Wang; Gaoxiang Ouyang
Journal:  ScientificWorldJournal       Date:  2014-03-25

6.  Heterogeneous Ensemble Combination Search Using Genetic Algorithm for Class Imbalanced Data Classification.

Authors:  Mohammad Nazmul Haque; Nasimul Noman; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.